Premium
Indacaterol: a long‐acting beta 2 ‐ agonist taken once daily
Author(s) -
Chaplin Steve,
Roberts Michael
Publication year - 2010
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.693
Subject(s) - indacaterol , medicine , b2 receptor , agonist , beta (programming language) , adverse effect , pharmacology , receptor , bronchodilator , computer science , asthma , programming language , bradykinin
Indacaterol (Onbrez) is a new long‐acting beta 2 ‐agonist taken once daily for the treatment of COPD. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse effects, and Professor Michael Roberts assesses its place in therapy compared with current treatments. Copyright © 2010 Wiley Interface Ltd